Rebecca Wilcox
Principal Consultant and Managing Director, Minotaur Pharma.
The Pharmaceutical Development Conference and Exhibition (PDC) is set to return to Melbourne in 2027. Following three successful conferences, PDC 2027 will continue to provide a dedicated platform for bringing together professionals and organisations from across the pharmaceutical development industry.
Recognised as a unique conference of its kind in Australia, PDC connects professionals working in pharmaceutical manufacturing, formulation development, analytical method development, preclinical and clinical development, quality assurance, and regulatory affairs.
The conference also attracts pharmaceutical companies, product sponsors, research organisations, solution providers, and business development executives, providing opportunities to share industry insights, discuss challenges, explore advancements, and establish valuable professional connections.
The conference date and venue will be announced soon.
Stay tuned for further updates on PDC 2027.
Preclinical and Clinical Strategy
Chemistry, Manufacturing and Control
GMP, Quality and Validation
PDC 2027 brings together the brightest minds in pharmaceutical development. From clinical trials to regulatory affairs, we create the bridge for lasting collaborations that define the future of the industry.
Learn from industry leaders, innovators, and experts shaping the future of pharmaceutical development
Managing Director
Aphex Pharma Solutions
Site Head
Resolian
PDC 2027 brings together the industry's most forward-thinking organizations. From discovery to delivery, our sponsors create the bridge for lasting collaborations.
